These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 22047505)
1. Public perspectives about pharmacogenetic testing and managing ancillary findings. Haga SB; Tindall G; O'Daniel JM Genet Test Mol Biomarkers; 2012 Mar; 16(3):193-7. PubMed ID: 22047505 [TBL] [Abstract][Full Text] [Related]
2. Professional perspectives about pharmacogenetic testing and managing ancillary findings. Haga SB; Tindall G; O'Daniel JM Genet Test Mol Biomarkers; 2012 Jan; 16(1):21-4. PubMed ID: 21770772 [TBL] [Abstract][Full Text] [Related]
3. Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions. Haga SB; O'Daniel JM; Tindall GM; Lipkus IR; Agans R Genet Med; 2011 Aug; 13(8):723-8. PubMed ID: 21633294 [TBL] [Abstract][Full Text] [Related]
4. Impact of Previous Genetic Counseling and Objective Numeracy on Accurate Interpretation of a Pharmacogenetics Test Report. Drelles K; Pilarski R; Manickam K; Shoben AB; Toland AE Public Health Genomics; 2021; 24(1-2):26-32. PubMed ID: 33445171 [TBL] [Abstract][Full Text] [Related]
5. Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing. Haga SB; O'Daniel JM; Tindall GM; Mills R; Lipkus IM; Agans R Clin Genet; 2012 Aug; 82(2):115-20. PubMed ID: 22283474 [TBL] [Abstract][Full Text] [Related]